Safety and efficacy of immune checkpoint inhibitors in patients with cancer and preexisting autoimmune disease: A systematic review and meta-analysis in non-small cell lung cancer

被引:0
|
作者
Aung, Wint Yan
Lee, Chung-Shien
Morales, Jaclyn
Kohn, Nina
Rahman, Husneara
Seetharamu, Nagashree
机构
[1] Northwell Hlth, Manhasset, NY USA
[2] Northwell Hlth Canc Inst, New Hyde Pk, NY USA
[3] Feinstein Inst Med Res, Manhasset, NY USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9053
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Safety and Efficacy of Immune Checkpoint Inhibitors in Cancer Patients and Preexisting Autoimmune Disease: A Systematic Review and Meta-Analysis in Non-Small-Cell Lung Cancer
    Aung, Wint Yan
    Lee, Chung-Shien
    Morales, Jaclyn
    Rahman, Husneara
    Seetharamu, Nagashree
    [J]. CLINICAL LUNG CANCER, 2023, 24 (07) : 598 - 612
  • [2] Safety and efficacy of retreatment with immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis
    Cai, Zijing
    Zhan, Ping
    Song, Yong
    Liu, Hongbing
    Lv, Tangfeng
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2022, : 1555 - 1566
  • [3] Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis
    Yang, Fang
    Wang, Yucai
    Tang, Lin
    Mansfield, Aaron Scott
    Adjei, Alex A. A.
    Leventakos, Konstantinos
    Duma, Narjust
    Wei, Jia
    Wang, Lifeng
    Liu, Baorui
    Molina, Julian R. R.
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Efficacy and safety of immune checkpoint inhibitors with or without radiotherapy in metastatic non-small cell lung cancer: A systematic review and meta-analysis
    Liu, Zijing
    Xu, Tiankai
    Chang, Pengyu
    Fu, Weijia
    Wei, Jiaying
    Xia, Chengcheng
    Wang, Qiang
    Li, Man
    Pu, Xiaoyu
    Huang, Fuxue
    Ge, Chao
    Gao, Yan
    Gong, Shouliang
    Liu, Chengjiang
    Dong, Lihua
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [5] Safety and efficacy of radiotherapy/chemoradiotherapy combined with immune checkpoint inhibitors for non-small cell lung cancer: A systematic review and meta-analysis
    Wu, Jing
    Ni, Tingting
    Deng, Rong
    Li, Yan
    Zhong, Qin
    Tang, Fei
    Zhang, Qi
    Fang, Chunju
    Xue, Yingbo
    Zha, Yan
    Zhang, Yu
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [6] Efficacy and Safety of Immune Checkpoint Inhibitors (ICI) in Resectable Non-Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis
    Xiao, T.
    Verma, S.
    Boldt, G.
    Rajeh, A.
    Breadner, D.
    Raphael, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (01): : E6 - E6
  • [7] Efficacy and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer: A systematic review and meta-analysis
    Feng, Yu
    Tao, Yunxia
    Chen, Haizhu
    Zhou, Yu
    Tang, Le
    Liu, Chenwei
    Hu, Xingsheng
    Shi, Yuankai
    [J]. THORACIC CANCER, 2023, 14 (25) : 2536 - 2547
  • [8] SAFETY AND EFFICACY FOLLOWING IMMUNE CHECKPOINT INHIBITORS THERAPIES IN PATIENTS WITH CANCER AND PREEXISTING AUTOIMMUNE DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES
    Xie, Wenhui
    Huang, Hong
    Xiao, Shiyu
    Zhang, Zhuoli
    [J]. INTERNAL MEDICINE JOURNAL, 2020, 50 : 5 - 5
  • [9] Smoking history and the efficacy of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis
    Chen, Da-Li
    Li, Qing-Yuan
    Tan, Qun-You
    [J]. JOURNAL OF THORACIC DISEASE, 2021, 13 (01) : 220 - U123
  • [10] Sarcopenia affects clinical efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients: A systematic review and meta-analysis
    Wang, Jiajun
    Cao, Liu
    Xu, Shun
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 88